Accrued Liabilities, Current of Protagenic Therapeutics, Inc.\new from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Protagenic Therapeutics, Inc.\new quarterly Accrued Liabilities, Current in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • Protagenic Therapeutics, Inc.\new Accrued Liabilities, Current for the quarter ending 31 Dec 2025 was $252,947.
Source SEC data
View on sec.gov
Accrued Liabilities, Current, Quarterly (USD)

Protagenic Therapeutics, Inc.\new Quarterly Accrued Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $252,947 31 Dec 2025 10-Q 09 Mar 2026 2026 Q3
Q3 2025 $407,975 30 Sep 2025 10-Q 26 Nov 2025 2026 Q2
Q2 2025 $505,821 30 Jun 2025 10-QT 10 Sep 2025 2026 Q1
Q1 2025 $249,063 31 Mar 2025 10-Q 09 Mar 2026 2026 Q3
Q3 2011 $6,799,000 30 Sep 2011 10-Q 14 Nov 2011 2011 Q3
Q2 2011 $5,023,000 30 Jun 2011 10-Q/A 07 Sep 2011 2011 Q2
Q4 2010 $5,172,000 31 Dec 2010 10-Q 14 Nov 2011 2011 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.